Point-of-Care Platform Blood Biomarker Testing of GFAP versus S100B for Prediction of Traumatic Brain Injuries: a TRACK-TBI study.

GFAP is FDA-cleared to determine need for head CT within 12 hours after mild TBI (GCS 13-15); S100B serves this function in Europe. This Phase 1 Biomarker Cohort analysis of the multicenter, observ...